<DOC>
	<DOCNO>NCT00663897</DOCNO>
	<brief_summary>Functional dyspepsia common symptom complex significant impact quality life . There standard treatment functional dyspepsia therapeutic efficacy proton pump inhibitor ( PPI ) prokinetic agent prove subset patient . This study two aim : - first compare therapeutic efficacy lansoprazole ( PPI ) mosapride ( prokinetic agent ) functional dyspepsia - second investigate whether different subgroup functional dyspepsia ( e.g. , epigastric pain syndrome postprandial distress syndrome ) respond differently PPI prokinetic agent .</brief_summary>
	<brief_title>Lansoprazole Versus Mosapride Functional Dyspepsia</brief_title>
	<detailed_description>Eligible outpatient presentation dyspepsia enrol fulfilled criterion ROME III criterion . A trained assistant help eligible patient complete ROME III standard questionaire , brief symptom rating scale ( BSRS ) , Maudsley Personality Inventory ( MPI ) . The enrolled patient randomize either lansoprazole mosapride group 14-day treatment . Before start medication , right complete medication , 1 month medication , enrol patient complete standardized severity questionnaire ( Hong-Kong Index ) evaluate severity dyspeptic symptom . Symptom improvement determine .</detailed_description>
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Somatoform Disorders</mesh_term>
	<mesh_term>Dyspepsia</mesh_term>
	<mesh_term>Gastritis</mesh_term>
	<mesh_term>Lansoprazole</mesh_term>
	<mesh_term>Dexlansoprazole</mesh_term>
	<mesh_term>Mosapride</mesh_term>
	<criteria>age 20 year old diagnosis functional dyspepsia fulfil RomeIII criterion outpatient age less 20 year organic lesion include ulcer , tumor , bleeding , vasculopathy esophagitis demonstrate upper endoscopy concurrent illness malignancy , diabetes mellitus , liver cirrhosis , renal failure porphyria diagnosis organic disease dyspeptic symptom treat physician history abdominal surgery concurrent user aspirin NSAID history allergy severe side effect lansoprazole mosapride pregnant lactating woman</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>90 Years</maximum_age>
	<verification_date>October 2009</verification_date>
	<keyword>functional dyspepsia</keyword>
	<keyword>epigastric pain syndrome</keyword>
	<keyword>postprandial distress syndrome</keyword>
	<keyword>proton pump inhibitor</keyword>
	<keyword>5 HT-4 receptor agonist</keyword>
</DOC>